We provide our excellent experiences to our customer
Flow Cytometer
Flow Cytometer >ACEA > Flow Cytometer
 
Novo Cyte

¡Ø °í°´´ÔÀÇ ¸ð´ÏÅÍ Çػ󵵿¡ µû¶ó »óÇ°»ö»óÀÌ Á¶±Ý¾¿ ´Þ¶óÁú ¼ö ÀÖ½À´Ï´Ù.
Novo Cyte
  
   ÆäÀ̽ººÏ   Æ®À§ÅÍ
 
Novo Cyte Á¦Ç°»ó´ã¹®ÀÇ

Ư¡
  • Çâ»óµÈ °¨µµ¿Í ºÐÇØ´ÉÀ¸·Î ÃÖ´ë 17°³ÀÇ ÆĶó¹ÌÅ͸¦ °ËÃâ °¡´ÉÇÑ °­·ÂÇÑ ¼º´É
  • Á÷°üÀûÀÎ °í±Þ µ¥ÀÌÅÍ ºÐ¼® ´É·ÂÀº ¶Ù¾î³­ À¯¿ë¼º ¹× ÀÚµ¿È­µÈ ±â±â À¯Áöº¸¼ö ±â´É Á¦°ø
  • ¸ÂÃãÇü »ùÇøµÀº 1~3°³ ·¹ÀÌÀú ¿É¼Ç, ±³Ã¼ °¡´ÉÇÑ ÇÊÅÍ, ´ÙÁß »ùÇøµ ¿É¼Ç ¹× À¯¿¬ÇÑ ºÐ¼® Æ÷¸Ë Æ÷ÇÔ
  • °íÁ¤µÈ ±¤ÇÐÀû Á¤·Ä, 24ºñÆ® ÃøÁ¤ ¹üÀ§, PMT Àü¾Ð Á¶Àý ºÒÇÊ¿ä, Á¤È®ÇÑ ºÎÇÇ ±â¹Ý ¼¼Æ÷ Ä«¿îÆ®, ½Ç½Ã°£À¸·Î À¯Ã¼ »óŸ¦ ¸ð´ÏÅ͸µÇÏ´Â ¾Ð·Â ¼¾¼­¿Í ÀÚµ¿È­µÈ ¼¼Ã´ ¹× ¿À¿° Á¦°Å ÀýÂ÷·Î À¯¿ë¼º Çâ»ó
  • NovoExpress ¼ÒÇÁÆ®¿þ¾î´Â Á÷°üÀûÀÌ¸ç »ç¿ëÇϱ⠽±½À´Ï´Ù. À¯¿¬ÇÑ ºÐ¼® ÅÛÇø´°ú Ç÷ÎÆà µµ±¸·Î ½Ã°£ Àý¾à ¹× µ¥ÀÌÅÍ ºÐ¼® È¿À² Çâ»ó
»ç¾ç¼­
±Ô°Ý(WxDxH)
  • 60 cm x 45 cm x 39 cm
±íÀÌ
  • 45 cm
³ôÀÌ
  • 39 cm
·¹ÀÌÀú ±¸¼º
  • ÆĶõ»ö
  • ÆĶõ»ö/»¡°£»ö
  • »¡°£»ö/³ë¶õ»ö/ÆĶõ»ö
  • º¸¶ó»ö/ÆĶõ»ö
  • º¸¶ó»ö/ÆĶõ»ö/»¡°£»ö
  • º¸¶ó»ö/³ë¶õ»ö/ÆĶõ»ö
  • ³ë¶õ»ö
  • ³ë¶õ»ö/ÆĶõ»ö
·¹ÀÌÀú ¼ö
  • 1
  • 2
  • 3
·¹ÀÌÀú ÆÄÀå
  • 405 nm
  • 488 nm
  • 561 nm
  • 637 nm
¹«°Ô
  • 39 kg
»ùÇøµ Æ÷¸Ë
  • 12 x 75mm Æ©ºê
  • 1.5mL Æ©ºê
  • 2mL Æ©ºê
Æø
  • 60 cm
Çü±¤ ä³Î
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 13
  • 14
  • 15
ÀÀ¿ë ºÐ¾ß

¼¼Æ÷ »ç¸ê ºÐ¼®

¼¼Æ÷ »ç¸ê ¶Ç´Â ¼¼Æ÷¿¹Á¤»ç(programmed cell death)´Â ¼¼Æ÷°¡ Á×´Â ¹æ½ÄÀ» Á¶ÀýÇÏ´Â °úÁ¤À¸·Î ¼¼Æ÷¸¦ ¼öÃà, ÀÀÃàÇÏ°Ô Çϴ ƯÁ¤ °æ·Î¸¦ È°¼ºÈ­ÇÏ¿© °á°úÀûÀ¸·Î ½Ä¼¼Æ÷ÀÛ¿ë¿¡ ÀÇÇØ Á¦°ÅµË´Ï´Ù. ÀÌ´Â ÅëÁ¦ÇÒ ¼ö ¾øÀÌ Á׾ ºÐ¿­µÇ¾î ¸é¿ª ¹ÝÀÀÀ» È°¼ºÈ­½ÃÅ°´Â À¯ÇØÇÑ ¿µÇâÀ» ÃÊ·¡ÇÏ´Â ±«»ç ¼¼Æ÷ Á×À½°ú ¶Ñ·ÇÇÑ Â÷À̸¦ º¸¿©ÁÝ´Ï´Ù. µû¶ó¼­ »ç¸ê ¼¼Æ÷´Â ¸Å¿ì Áú¼­ÀÖ´Â ¹æ½ÄÀ¸·Î Á׾ ºÎ±ÙÀÇ ¼¼Æ÷¿Í Á¶Á÷ Æı«¸¦ ¸·¾Æ ÁÝ´Ï´Ù.

¼¼Æ÷ Á×À½À» ÃøÁ¤ÇÏ°í ¼¼Æ÷ »ç¸ê ¶Ç´Â ±«»ç¸¦ ±¸º°ÇÏ´Â ´Ù¾çÇÑ ¹æ¹ýÀÌ ÀÖ½À´Ï´Ù. ÀÚµ¿ º¸Á¤ ¼³Á¤ ¹× ±¤¹üÀ§ÇÑ Çü±¤ °ËÃâ ÃøÁ¤ ¹üÀ§¸¦ °¡Áø NovoCyte À¯¼¼Æ÷ ºÐ¼®±â¸¦ »ç¿ëÇϸé PMT Àü¾Ð Á¶ÀýÀÌ ÇÊ¿ä ¾øÀÌ ÀÌ·¯ÇÑ ºÐ¼®¿¡ ´ëÇÑ °£ÆíÇÑ Á¤·®ÀÌ °¡´ÉÇÕ´Ï´Ù.
 

¸é¿ª Ç¥ÇöÇü

¸é¿ª »óÅ´ Áúº´ »óÅÂ, Ä¡·á È¿À²¼º ¹× ¹é½Å°ú °°Àº ¿ÜºÎ Àڱؿ¡ ´ëÇÑ ¹ÝÀÀ°ú °ü·ÃÀÌ ÀÖ½À´Ï´Ù. ¸é¿ª Ç¥ÇöÇü ºÐ¼®À¸·Î Èĺ¸ ¼¼Æ÷ À¯Çü, ÇÏÀ§ µî±Þ ¹× ±â´ÉÀ» ½Å¼ÓÇÏ°Ô ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸é¿ª ¼¼Æ÷´Â ¹é½ÅÀÇ ¸é¿ª¿ø¼º°ú ±× È¿À²¼º¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖÀ¸¹Ç·Î ´Ù¾çÇÑ ¸é¿ª ¼¼Æ÷ Áý´ÜÀÇ ºóµµ¿Í ´ÜÇÙ±¸, NK ¼¼Æ÷, T¿Í B ¼¼Æ÷ °°Àº ƯÁ¤ ¼¼Æ÷ ÇÏÀ§ ÁýÇÕÀÇ ºÐÈ­ ¹× È°¼ºÈ­ »óŸ¦ ¸ð´ÏÅ͸µÇÏ´Â °ÍÀÌ ÇʼöÀûÀÔ´Ï´Ù. NovoCyte À¯¼¼Æ÷ ºÐ¼®±â´Â ¿©·¯ ¹éÇ÷±¸¸¦ µ¿½Ã¿¡ Á¤·®ÇÒ ¼ö ÀÖ¾î ȯÀÚÀÇ ¸é¿ª »óŸ¦ º¸´Ù Àß ÀÌÇØÇÏ°í Àü¿°¼º Áúȯ¿¡ ´ëÇÑ ¸é¿ª ¹ÝÀÀÀ» °¨½ÃÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÚ¼¼È÷ ¾Ë¾Æº¸±â >


¼¼Æ÷³» ´Ü¹éÁú °ËÃâ

¼¼Æ÷³» ´Ü¹éÁúÀÇ °ËÃâ ¹× ºÐ¼®À» ÅëÇØ ¼¼Æ÷ ÇÏÀ§ Áý´Ü ¹× ¼¼Æ÷ °úÁ¤¿¡ ´ëÇÑ Ãß°¡ÀûÀΠƯ¼º ±Ô¸íÀÌ °¡´ÉÇÕ´Ï´Ù. ¼¼Æ÷ Ç¥¸é¿¡ ÀÖÁö ¾ÊÀº ´Ü¹éÁúÀ» ºÐ¼®ÇÏ·Á¸é ¼¼Æ÷ °íÁ¤ ¹× Åõ°úÈ­¸¦ °ÅÃÄ¾ß ÇÕ´Ï´Ù. ±×·¯³ª ¸¹Àº ÀλêÈ­ ƯÀÌÀûÀÎ Ç×ü´Â ¼¼Æ÷³» ¿°»ö¿¡ »ç¿ëµÇ´Â ÀϹÝÀûÀÎ ¼¼Ã´¾× ±â¹Ý Åõ°úÈ­ ¹æ¹ý°ú ȣȯµÇÁö ¾Ê½À´Ï´Ù. ÀλêÈ­ ƯÀÌÀûÀÎ Ç×ü¿¡ ´ëÇÑ ÀûÀýÇÑ °íÁ¤ ¹× Åõ°úÈ­ ¹æ¹ýÀ» °áÁ¤ÇÒ ¶§ Ưº°ÇÑ ÁÖÀÇ°¡ ÇÊ¿äÇÕ´Ï´Ù. °¡Àå ÀϹÝÀûÀÎ ¹æ¹ýÀº °íÁ¤ ½Ã 1.5% ÆĶóÆ÷¸§¾Ëµ¥È÷µå¸¦ »ç¿ëÇÑ ´ÙÀ½ Åõ°úÈ­¸¦ À§ÇØ 100% ¸Þź¿ÃÀ» »ç¿ëÇÕ´Ï´Ù. ÀÌ ¹æ¹ýÀº ¸¹Àº Ç×ü¿¡ Àû¿ëÇÒ ¼ö ÀÖÁö¸¸ ¸ðµç ÀλêÈ­ ƯÀÌÀûÀÎ Ç×ü¿¡ Àû¿ëÇÒ ¼ö ÀÖ´Â °ÍÀº ¾Æ´Õ´Ï´Ù.

¶ÇÇÑ, ºñµ¿Áú¼º ½Ã·á¿¡¼­ ´Ù¾çÇÑ ¼¼Æ÷ Áý´ÜÀ» ½Äº°ÇÏ·Á¸é Ç¥¸éÀÇ ´Ü¹éÁú°ú °áÇÕµÈ ÀλêÈ­ ´Ü¹éÁúÀ» ¿°»öÇØ¾ß ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿¡ÇÇÅäÇÁÀÇ °íÁ¤Á¦¿¡ ´ëÇÑ ¹Î°¨¼ºÀ» Ưº°È÷ ÁÖÀǸ¦ ±â¿ï¿©¾ß Çϸç, ¿¡ÇÇÅäÇÁ¸¦ ¼Õ»ó½ÃÅ°Áö ¾Êµµ·Ï ¿¹¹æÁ¶Ä¡¸¦ ÃëÇØ¾ß ÇÕ´Ï´Ù. µû¶ó¼­ °íÁ¤ Àü¿¡ ƯÁ¤ Ç¥¸é ¸¶Ä¿¿¡ ´ëÇØ ½Ã·á¸¦ ¹Ì¸® ¿°»öÇØ¾ß ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÚ¼¼È÷ ¾Ë¾Æº¸±â >


¼¼Æ÷ Áֱ⠺м®

Á¤»óÀûÀÎ Àΰ£ ü¼¼Æ÷´Â ÀÏÁ¤ÇÑ ¾çÀÇ DNA¸¦ Æ÷ÇÔÇÏ´Â À̹èüÀÔ´Ï´Ù. ¼¼Æ÷ ÁֱⰡ ÁøÇàµÇ´Â µ¿¾È DNA ÇÕ¼ºÀ¸·Î Àüü DNA ÇÔ·®ÀÌ µÎ ¹è·Î ´Ã¾î³ª°í À¯»ç ºÐ¿­ ÈÄ Á¤»óÀûÀÎ DNA ÇÔ·®À» ȸº¹ÇÕ´Ï´Ù. NovoCyte À¯¼¼Æ÷ ºÐ¼®±â¸¦ »ç¿ëÇÏ¸é »ó¼¼ÇÑ ¼¼Æ÷ Áֱ⠺м®À» ¼öÇàÇÏ¿© Á¾¾ç ¼¼Æ÷ ºÐÈ­, ¼¼Æ÷ º¯Çü ¹× ¼¼Æ÷ È­ÇÕ¹° °£ÀÇ »óÈ£ ÀÛ¿ëÀ» ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

±×¸²: 10µg/M MG132 ¶Ç´Â 500µg/M 5-FU·Î 16½Ã°£ ó¸®ÇÑ ÈÄ, ACEA NovoCyte À¯¼¼Æ÷ ºÐ¼®±â·Î A549 ¼¼Æ÷ÀÇ ¼¼Æ÷ Áֱ⠺ÐÆ÷¸¦ ºÐ¼®Çß½À´Ï´Ù. NovoExpress¿¡ Æ÷ÇÔµÈ ¼¼Æ÷ Áֱ⠺м® ¸ðµâÀ» »ç¿ëÇϸé Ç÷Կ¡ G0/G1 ´Ü°è(³ì»ö), S ´Ü°è(³ë¶õ»ö) ¹× G2/M ´Ü°è(ÆĶõ»ö)ÀÇ ¼¼Æ÷°¡ Ç¥½ÃµË´Ï´Ù. ÀÏ¹Ý ¹Ìó¸® ¼¼Æ÷¿Í ºñ±³ÇÏ¿© MG132 ó¸® ¼¼Æ÷´Â G2/M ´Ü°è¿¡¼­ Á¤ÁöµÈ ¹Ý¸é 5-FU ó¸® ¼¼Æ÷´Â G0/G1 ´Ü°è¿¡¼­ Á¤ÁöµÇ¾ú½À´Ï´Ù.

ÀÚ¼¼È÷ ¾Ë¾Æº¸±â >


¼¼Æ÷ Áõ½Ä

¼¼Æ÷ Áõ½ÄÀº Çʼö ±â´ÉÀ̸ç Á¶ÀýµÇÁö ¾ÊÀ» °æ¿ì Áúº´À» À¯¹ßÇÒ ¼ö ÀÖ´Â °íµµ·Î ±¸Á¶È­µÈ À̺¥Æ®ÀÔ´Ï´Ù. Àý´ë ¼¼Æ÷ ¼ö ¶Ç´Â CFSE¿Í °°Àº ¿°·á·Î Áõ½ÄÀ» ÃøÁ¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. CFSE·Î ¶óº§¸µµÈ ¼¼Æ÷°¡ ºÐÇÒµÉ ¶§, ¿°·á´Â µþ¼¼Æ÷ »çÀÌ¿¡¼­ ±ÕµîÇÏ°Ô ºÐÇÒµÇ°í ¿°·á°¡ Áö¼ÓÀûÀ¸·Î Èñ¼®µÊ¿¡ µû¶ó ½Ã°£¿¡ µû¸¥ CFSE Çü±¤ ¼Õ½ÇÀ» ÃøÁ¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿°·áÀÇ Æò±Õ Çü±¤ °­µµ(MFI)¸¦ ½Ã°£¿¡ µû¸¥ ¼¼Æ÷ ³óµµ·Î Ç÷ÔÇÏ¿© µÑ »çÀÌÀÇ ¹Ýºñ·Ê °ü°è¸¦ ³ªÅ¸³À´Ï´Ù. ÀÌ·¯ÇÑ À¯ÇüÀÇ ºÐ¼®Àº Á¾Á¾ T ¸²ÇÁ±¸ È°¼ºÈ­ÀÇ º¯È­¸¦ °üÂûÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù.

 
±×¸²: CFSE¸¦ »ç¿ëÇÑ Jurkat T ¼¼Æ÷ÀÇ Áõ½Ä ÃøÁ¤. A) Jurkat T ¼¼Æ÷¸¦ CFSE·Î ¶óº§¸µÇÏ°í NovoCyte À¯¼¼Æ÷ ºÐ¼®±â¿¡¼­ ½Ã°£ °æ°ú¿¡ µû¸¥ ¼¼Æ÷ ºÐ¿­À» ÃøÁ¤ÇÏ¿© ºÐ¼®ÇÕ´Ï´Ù. °¢ ÇÇÅ©´Â °³º° ½ÃÁ¡À» ³ªÅ¸³À´Ï´Ù. B) ¼¼Æ÷°¡ ºÐ¿­ÇÒ ¶§ »ý¼ºµÈ ½ÅÈ£ÀÇ Èñ¼®À» »ç¿ëÇÏ¿© ½Ã°£ °æ°ú¿¡ µû¸¥ CFSEÀÇ Æò±Õ Çü±¤ °­µµ(MFI)¸¦ ÃøÁ¤ÇÏ´Â ÇÑÆí, Àý´ë ¼¼Æ÷ ¼ö¸¦ ³ªÅ¸³À´Ï´Ù.
 

ÀÚ·á
ÀÀ¿ë ÀÚ·á

Analysis of Phosphorylated STAT Protein Signaling in Lymphocytes Using Flow Cytometry

Examines the phosphorylation of signal transducer and activator of transcription (STAT) proteins in response to cytokine stimulation using a phosphoflow technique.

Osmotic Fragility of Red Blood Cells Quantified on the Agilent NovoCyte Flow Cytometer

Cellular osmotic fragility was analyzed on the Agilent NovoCyte flow cytometer to investigate the resistance of red blood cells to salinity and temperature changes.

Novel Methods to Analyze Platelet Activation with the Agilent NovoCyte Flow Cytometer

An application measuring platelet function by expression of CD62P and frequency of platelet-leukocyte aggregates.

Inhibition of T Cell Receptor Signaling‑Mediated Calcium Flux in T cells

Demonstrates the capability of the Agilent NovoCyte flow cytometer to quantify dynamic changes in intracellular Ca2+ by measuring calcium flux in Jurkat T cells.

Examining the Kinetics of Neutrophil Phagocytosis by Flow Cytometry

An analysis of neutrophil phagocytosis under various conditions using the Agilent NovoCyte flow cytometer.

Tumor Cell Killing by T Cells

A demonstration of cytotoxic T lymphocyte-mediated destruction of tumor cells and the corresponding secretion of cytokines using an Agilent xCELLigence instrument.

µ¥ÀÌÅÍ ½ÃÆ®
Áö¿ø
¼³¸í ½ÃÆ®

Dell Ownership Transfer Process

Dell Ownership transferring process

Åø

SpectraViewer µµ±¸

Spectra Viewer µµ±¸¸¦ »ç¿ëÇÏ¿© À¯¼¼Æ÷ ºÐ¼®±â¿Í ȣȯ °¡´ÉÇÑ Çü±¤»ö¼Ò¸¦ ã¾Æº¸¼¼¿ä

 

FluoroFinder Panel Builder

½ÇÇèÀ» À§ÇØ ´Ù»ö Ç×ü ÆгÎÀ» ¸¸µå´Â µ¥ µµ¿òÀÌ ÇÊ¿äÇϼ¼¿ä? FluoroFinder Panel Builder¸¦ »ç¿ëÇØ º¸¼¼¿ä!

ºñµð¿À

°ü·Ã Á¦Ç°
Example category image description

NovoExpress ¼ÒÇÁÆ®¿þ¾î

NovoExpress ¼ÒÇÁÆ®¿þ¾î´Â ¿¬±¸ÀÚµéÀÌ È¿À²ÀûÀÎ ½Ã·á ¼öÁý°ú ºÐ¼®À» ¼öÇàÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù.

Ä«Å×°í¸®: À¯¼¼Æ÷ ºÐ¼® ¼ÒÇÁÆ®¿þ¾î
Example category image description

NovoSampler Pro

ÀÚµ¿È­µÈ »ùÇøµ, ³·Àº ij¸®¿À¹ö, À¯¿¬ÇÑ microplate ±â´É, ±Ëµµ ÁøÅÁ µî

Ä«Å×°í¸®: À¯¼¼Æ÷ ºÐ¼®±â
Example category image description

À¯¼¼Æ÷ ºÐ¼®±â¿ë ±¤ÇÐ ÇÊÅÍ ¾î¼Àºí¸®

ÃÖ´ë 25°³ÀÇ Çü±¤ °ËÃâ ä³ÎÀ» À§ÇÑ ±¤ÇÐ ÇÊÅÍ, LP, SP ¹× BP ÇÊÅÍ

Ä«Å×°í¸®: À¯¼¼Æ÷ ºÐ¼®±â
Example category image description

À¯¼¼Æ÷ ºÐ¼®±â¿ë À¯Ã¼ ½Ã½ºÅÛ ¿ë¾×

À¯¼¼Æ÷ ºÐ¼®±â ÀÛµ¿¿ë À¯Ã¼ ¿ë¾×

Ä«Å×°í¸®: À¯¼¼Æ÷ ºÐ¼®±â
Example category image description

À¯¼¼Æ÷ ºÐ¼®¿ë À¯Ã¼ ½Ã½ºÅÛ °ø±ÞÇ°

À¯Ã¼ ¿ë¾×Àº À¯¼¼Æ÷ ºÐ¼®±â°¡ ÃÖÀûÀÇ Á¶°Ç¿¡¼­ ÀÛµ¿Çϵµ·Ï º¸ÀåÇÕ´Ï´Ù.

Ä«Å×°í¸®: À¯¼¼Æ÷ ºÐ¼®±â
Example category image description

À¯¼¼Æ÷ ºÐ¼®¿ë À¯Ã¼ ½Ã½ºÅÛ À¯Áöº¸¼ö

ÃÖÀûÀÇ ¼º´É°ú À¯¿¬ÇÑ ¿öÅ©Ç÷θ¦ Áö¿øÇÏ´Â À¯¼¼Æ÷ ºÐ¼®±â À¯Áöº¸¼ö Å°Æ®

Ä«Å×°í¸®: À¯¼¼Æ÷ ºÐ¼®±â